9,314 Shares in Nutex Health Inc. $NUTX Bought by Principal Financial Group Inc.

Principal Financial Group Inc. purchased a new stake in Nutex Health Inc. (NASDAQ:NUTXFree Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 9,314 shares of the company’s stock, valued at approximately $962,000. Principal Financial Group Inc. owned 0.17% of Nutex Health at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of NUTX. Bank of America Corp DE lifted its position in Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after acquiring an additional 2,043 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Nutex Health by 17.9% during the first quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock valued at $852,000 after buying an additional 2,748 shares during the last quarter. Jane Street Group LLC purchased a new position in shares of Nutex Health during the first quarter valued at approximately $522,000. KLP Kapitalforvaltning AS bought a new stake in Nutex Health during the second quarter worth $112,000. Finally, Allianz Asset Management GmbH purchased a new stake in Nutex Health in the 2nd quarter valued at $314,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Stock Performance

Shares of NUTX opened at $104.51 on Thursday. Nutex Health Inc. has a 1 year low of $40.67 and a 1 year high of $193.07. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 3.18. The stock’s fifty day moving average price is $152.85 and its two-hundred day moving average price is $123.74. The firm has a market cap of $738.89 million, a PE ratio of 5.65 and a beta of -0.01.

Nutex Health (NASDAQ:NUTXGet Free Report) last posted its quarterly earnings results on Tuesday, November 18th. The company reported $7.76 earnings per share (EPS) for the quarter, beating the consensus estimate of ($5.43) by $13.19. Nutex Health had a net margin of 11.62% and a return on equity of 37.44%. The company had revenue of $243.99 million for the quarter, compared to analyst estimates of $221.93 million.

Insider Activity

In related news, CFO Jon Christian Bates acquired 750 shares of the company’s stock in a transaction that occurred on Tuesday, November 25th. The shares were acquired at an average price of $136.71 per share, with a total value of $102,532.50. Following the acquisition, the chief financial officer owned 5,638 shares of the company’s stock, valued at approximately $770,770.98. This trade represents a 15.34% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 36.92% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 29th. Wall Street Zen upgraded shares of Nutex Health from a “buy” rating to a “strong-buy” rating in a report on Friday, November 28th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.

Read Our Latest Stock Analysis on NUTX

Nutex Health Profile

(Free Report)

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

Further Reading

Want to see what other hedge funds are holding NUTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutex Health Inc. (NASDAQ:NUTXFree Report).

Institutional Ownership by Quarter for Nutex Health (NASDAQ:NUTX)

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.